Skip to content

GANX - Gain Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchG

Gain Therapeutics Inc

GANX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

G

GANXGain Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $4.34
52-wk low: $1.53
Prev close: $3.27
Mkt cap: $90.3M
Beta: 0.20
P/S: 255.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$5.6M

MW
Marshall Wace
Q2 2026 13F
$3.9M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 21.4% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $90M

Valuation

P/S255.50
P/B7.85

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: GANX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $90.34M
Beta: 0.20

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

7.8x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-268.3%

$314K

position

SQ

Squarepoint

Q2 2026 13F

$277K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for GANX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.11+21.4%

-$0.14 expected

Next report

What the street expects next

-268.3%

ROA-95.5%

Growth

Beta0.20